TrialThe Lancet. Microbe2025

Interactions between live attenuated influenza vaccine and nasopharyngeal microbiota among children aged 24-59 months in The Gambia: a phase 4, open-label, randomised controlled trial.

Chikondi Peno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.